Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
30791 | 163 | 38.9 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
441 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 26474 |
306 | 2 | TRAIL//SURVIVIN//APOPTOSIS | 18497 |
30791 | 1 | PUMA//PUMA GENE//P53 UPREGULATED MODULATOR OF APOPTOSIS PUMA | 163 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PUMA | authKW | 1640913 | 34% | 16% | 56 |
2 | PUMA GENE | authKW | 374669 | 1% | 100% | 2 |
3 | P53 UPREGULATED MODULATOR OF APOPTOSIS PUMA | authKW | 249778 | 1% | 67% | 2 |
4 | 2 3 DCPE | authKW | 187334 | 1% | 100% | 1 |
5 | ADENOVIRUS EXPRESSING P53 | authKW | 187334 | 1% | 100% | 1 |
6 | AKT FOXO3A SIGNALING | authKW | 187334 | 1% | 100% | 1 |
7 | C JUN N TERMINAL KINASE JNK ACTIVATION | authKW | 187334 | 1% | 100% | 1 |
8 | C4ORF7 | authKW | 187334 | 1% | 100% | 1 |
9 | CANCER BCL 2 FAMILY PROTEINS | authKW | 187334 | 1% | 100% | 1 |
10 | CIB BIM NANOMED VHIR | address | 187334 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1318 | 47% | 0% | 76 |
2 | Cell Biology | 465 | 28% | 0% | 46 |
3 | Biochemistry & Molecular Biology | 100 | 24% | 0% | 39 |
4 | Genetics & Heredity | 91 | 11% | 0% | 18 |
5 | Medicine, Research & Experimental | 46 | 7% | 0% | 12 |
6 | Gastroenterology & Hepatology | 15 | 4% | 0% | 6 |
7 | Biophysics | 12 | 4% | 0% | 7 |
8 | Hematology | 9 | 3% | 0% | 5 |
9 | Pharmacology & Pharmacy | 8 | 7% | 0% | 11 |
10 | Cell & Tissue Engineering | 5 | 1% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CIB BIM NANOMED VHIR | 187334 | 1% | 100% | 1 |
2 | COMITE URO GYNECOL ONCOL | 187334 | 1% | 100% | 1 |
3 | EA 1773 | 187334 | 1% | 100% | 1 |
4 | HAEMATOL SA PATHOL HEAMATOL ONCOL | 187334 | 1% | 100% | 1 |
5 | HILLMAN CANC PAVIL PATHOL | 187334 | 1% | 100% | 1 |
6 | HILLMAN CANC PAVIL PHARMACOL | 187334 | 1% | 100% | 1 |
7 | HILLMAN CANC PHARMACOL | 187334 | 1% | 100% | 1 |
8 | HILMAN CANC | 187334 | 1% | 100% | 1 |
9 | INNOVAT ENGAGEMENTS | 187334 | 1% | 100% | 1 |
10 | JOHNS HOPKINS ONCOL HOWARD HUGHES MED | 187334 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2686 | 4% | 0% | 7 |
2 | CANCER BIOLOGY & THERAPY | 2397 | 4% | 0% | 6 |
3 | ONCOGENE | 1246 | 7% | 0% | 11 |
4 | MOLECULAR CANCER THERAPEUTICS | 1145 | 3% | 0% | 5 |
5 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 943 | 3% | 0% | 5 |
6 | IRANIAN JOURNAL OF BIOTECHNOLOGY | 939 | 1% | 1% | 1 |
7 | TRANSLATIONAL CANCER RESEARCH | 556 | 1% | 0% | 1 |
8 | ONCOTARGET | 542 | 4% | 0% | 6 |
9 | CELL DEATH AND DIFFERENTIATION | 528 | 2% | 0% | 3 |
10 | CANCER CELL | 487 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PUMA | 1640913 | 34% | 16% | 56 | Search PUMA | Search PUMA |
2 | PUMA GENE | 374669 | 1% | 100% | 2 | Search PUMA+GENE | Search PUMA+GENE |
3 | P53 UPREGULATED MODULATOR OF APOPTOSIS PUMA | 249778 | 1% | 67% | 2 | Search P53+UPREGULATED+MODULATOR+OF+APOPTOSIS+PUMA | Search P53+UPREGULATED+MODULATOR+OF+APOPTOSIS+PUMA |
4 | 2 3 DCPE | 187334 | 1% | 100% | 1 | Search 2+3+DCPE | Search 2+3+DCPE |
5 | ADENOVIRUS EXPRESSING P53 | 187334 | 1% | 100% | 1 | Search ADENOVIRUS+EXPRESSING+P53 | Search ADENOVIRUS+EXPRESSING+P53 |
6 | AKT FOXO3A SIGNALING | 187334 | 1% | 100% | 1 | Search AKT+FOXO3A+SIGNALING | Search AKT+FOXO3A+SIGNALING |
7 | C JUN N TERMINAL KINASE JNK ACTIVATION | 187334 | 1% | 100% | 1 | Search C+JUN+N+TERMINAL+KINASE+JNK+ACTIVATION | Search C+JUN+N+TERMINAL+KINASE+JNK+ACTIVATION |
8 | C4ORF7 | 187334 | 1% | 100% | 1 | Search C4ORF7 | Search C4ORF7 |
9 | CANCER BCL 2 FAMILY PROTEINS | 187334 | 1% | 100% | 1 | Search CANCER+BCL+2+FAMILY+PROTEINS | Search CANCER+BCL+2+FAMILY+PROTEINS |
10 | GASTRO INTESTINAL SYNDROME | 187334 | 1% | 100% | 1 | Search GASTRO+INTESTINAL+SYNDROME | Search GASTRO+INTESTINAL+SYNDROME |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SUN, J , SUN, QH , BROWN, MF , DUDGEON, C , CHANDLER, J , XU, X , SHU, YQ , ZHANG, L , YU, J , (2012) THE MULTI-TARGETED KINASE INHIBITOR SUNITINIB INDUCES APOPTOSIS IN COLON CANCER CELLS VIA PUMA.PLOS ONE. VOL. 7. ISSUE 8. P. - | 18 | 40% | 11 |
2 | ZHANG, XL , LU, HF , WANG, YB , LIU, CJ , ZHU, WF , ZHENG, SY , WAN, FS , (2015) TAURINE INDUCES THE APOPTOSIS OF BREAST CANCER CELLS BY REGULATING APOPTOSIS-RELATED PROTEINS OF MITOCHONDRIA.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. VOL. 35. ISSUE 1. P. 218 -226 | 15 | 42% | 5 |
3 | ZHANG, LL , WANG, HA , LI, W , ZHONG, JC , YU, RC , HUANG, XF , WANG, HH , TAN, ZK , WANG, JG , ZHANG, YJ , (2017) PAZOPANIB, A NOVEL MULTI-KINASE INHIBITOR, SHOWS POTENT ANTITUMOR ACTIVITY IN COLON CANCER THROUGH PUMA-MEDIATED APOPTOSIS.ONCOTARGET. VOL. 8. ISSUE 2. P. 3289 -3303 | 20 | 32% | 0 |
4 | HE, K , ZHENG, XN , ZHANG, L , YU, J , (2013) HSP90 INHIBITORS PROMOTE P53-DEPENDENT APOPTOSIS THROUGH PUMA AND BAX.MOLECULAR CANCER THERAPEUTICS. VOL. 12. ISSUE 11. P. 2559-2568 | 18 | 36% | 10 |
5 | YU, J , ZHANG, L , (2008) PUMA, A POTENT KILLER WITH OR WITHOUT P53.ONCOGENE. VOL. 27. ISSUE . P. S71 -S83 | 28 | 19% | 181 |
6 | ZHENG, XN , HE, K , ZHANG, L , YU, J , (2013) CRIZOTINIB INDUCES PUMA-DEPENDENT APOPTOSIS IN COLON CANCER CELLS.MOLECULAR CANCER THERAPEUTICS. VOL. 12. ISSUE 5. P. 777-786 | 16 | 37% | 7 |
7 | CHEN, DS , WEI, L , YU, J , ZHANG, L , (2014) REGORAFENIB INHIBITS COLORECTAL TUMOR GROWTH THROUGH PUMA-MEDIATED APOPTOSIS.CLINICAL CANCER RESEARCH. VOL. 20. ISSUE 13. P. 3472 -3484 | 15 | 33% | 21 |
8 | CARPENTER, RL , HAN, W , PAW, I , LO, HW , (2013) HER2 PHOSPHORYLATES AND DESTABILIZES PRO-APOPTOTIC PUMA, LEADING TO ANTAGONIZED APOPTOSIS IN CANCER CELLS.PLOS ONE. VOL. 8. ISSUE 11. P. - | 15 | 36% | 1 |
9 | HIKISZ, P , KILIANSKA, ZM , (2012) PUMA, A CRITICAL MEDIATOR OF CELL DEATH - ONE DECADE ON FROM ITS DISCOVERY.CELLULAR & MOLECULAR BIOLOGY LETTERS. VOL. 17. ISSUE 4. P. 646 -669 | 21 | 23% | 28 |
10 | MUSTATA, G , LI, M , ZEVOLA, N , BAKAN, A , ZHANG, L , EPPERLY, M , GREENBERGER, JS , YU, J , BAHAR, I , (2011) DEVELOPMENT OF SMALL-MOLECULE PUMA INHIBITORS FOR MITIGATING RADIATION-INDUCED CELL DEATH.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 11. ISSUE 3. P. 281-290 | 16 | 33% | 13 |
Classes with closest relation at Level 1 |